SCHEMBL4661816

SCHEMBL4661816

CCCCC1CC=CC=C1c1ccccc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 6/20 0.33
CHRM4 P08173 6/20 0.33
CHRM5 P08912 6/20 0.33
CHRM1 P11229 6/20 0.33
CHRM3 P20309 6/20 0.33
CYP3A4 P08684 3/20 0.32
ALDH1A1 P00352 2/20 0.32
CYP1A2 P05177 2/20 0.32
CYP2C9 P11712 2/20 0.32
GRM2 Q14416 1/20 0.32
LMNA P02545 1/20 0.32
MAPK1 P28482 1/20 0.32
CYP2C19 P33261 1/20 0.32
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
PTGS1 P23219 1/20 0.32
RAB9A P51151 1/20 0.32
NAPRT Q6XQN6 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4661320 0.95 CHRM2 (0.34) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL24796792 0.75
SCHEMBL27469177 0.74
SCHEMBL6548349 0.68 TSHR (0.34) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL23096934 0.67 KDM1A (0.34) CYP3A4ALDH1A1CYP1A2CYP2C9LMNA
SCHEMBL24633078 0.67 CFTR (0.31) CYP3A4ALDH1A1
SCHEMBL13782279 0.67 CFTR (0.31) CYP3A4ALDH1A1
SCHEMBL14974744 0.67 CFTR (0.32) CYP3A4
SCHEMBL14402475 0.67 HTT (0.31) ALDH1A1
SCHEMBL5545795 0.66 CFTR (0.44) CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1919907-A2 HETEROCYCLIC COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-05-14 EP disclosed
WO-2007026959-A2 DERIVATIVES OF 4-PIPERAZIN-1-YL-4-BENZ0 [B] THIOPHENE SUITABLE FOR THE TREATMENT OF CNS DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-03-08 WO disclosed